EFFECT OF RECEIVING INTRAVENOUS VITAMIN C ON DYSLIPIDEMIA IN PATIENTS UNDERGOING HEMODIALYSIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BINIAZ VAJIHE; TAYYBI ALI; EBADI ABBAS; SADEGHI SHERMEH MEHDI; NEMATI EGHLIM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download Full-Text

Persian Verion

View:

824

Download:

Cites:

Information Journal Paper

Title

EFFECT OF RECEIVING INTRAVENOUS VITAMIN C ON DYSLIPIDEMIA IN PATIENTS UNDERGOING HEMODIALYSIS

Author(s)

Keywords

CHRONIC KIDNEY DISEASEQ3

DYSLIPIDEMIAQ3

HEMODIALYSISQ3

HYPERLIPIDEMIAQ3

INTRAVENOUS VITAMIN CQ3

Abstract

Background: DYSLIPIDEMIA is one of the major causes of the production and progression of atherosclerosis in HEMODIALYSIS patients. Vitamin C is able to improve DYSLIPIDEMIA by reducing an oxidative stress.Aim: The aim of this study was to evaluate the effect of vitamin C supplementation on DYSLIPIDEMIA in HEMODIALYSIS patients.Methods: In a randomized, double-blind clinical trial, 160 patients with chronic renal failure were studied. They were divided into three groups (intervention, control and witness). In an intervention group, 250 mg from vitamin C was injected, three times weakly at the end of each dialysis session via the intravenous route, for 8 weeks. In the control group same amount of placebo saline was injected and in the witness group no intervention was performed. Required laboratory parameters including serum total cholestrole, triglyserid and HDL were measured at the beginning and end of the intervention. In order to analyze the data, SPSS statistical software was used, and test Chi square and ANOVA were performed. P value less than 0.05 is considered statistical significance.Results: No significant differences were observed in the serum levels of cholesterol, triglyceride and HDL between groups before and after the intervention.Conclusion: The results of this study demonstrated that 250 mg INTRAVENOUS VITAMIN C did not change serum levels of cholesterol, triglyceride and HDL.

Cites

No record.

References

No record.

Cite

APA: Copy

BINIAZ, VAJIHE, TAYYBI, ALI, EBADI, ABBAS, SADEGHI SHERMEH, MEHDI, & NEMATI, EGHLIM. (2013). EFFECT OF RECEIVING INTRAVENOUS VITAMIN C ON DYSLIPIDEMIA IN PATIENTS UNDERGOING HEMODIALYSIS. EVIDENCE BASED CARE, 3(2 (7)), 55-61. SID. https://sid.ir/paper/213305/en

Vancouver: Copy

BINIAZ VAJIHE, TAYYBI ALI, EBADI ABBAS, SADEGHI SHERMEH MEHDI, NEMATI EGHLIM. EFFECT OF RECEIVING INTRAVENOUS VITAMIN C ON DYSLIPIDEMIA IN PATIENTS UNDERGOING HEMODIALYSIS. EVIDENCE BASED CARE[Internet]. 2013;3(2 (7)):55-61. Available from: https://sid.ir/paper/213305/en

IEEE: Copy

VAJIHE BINIAZ, ALI TAYYBI, ABBAS EBADI, MEHDI SADEGHI SHERMEH, and EGHLIM NEMATI, “EFFECT OF RECEIVING INTRAVENOUS VITAMIN C ON DYSLIPIDEMIA IN PATIENTS UNDERGOING HEMODIALYSIS,” EVIDENCE BASED CARE, vol. 3, no. 2 (7), pp. 55–61, 2013, [Online]. Available: https://sid.ir/paper/213305/en

Related Journal Papers